Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Cervical Cancer

  Free Subscription


12.01.2026

1 ACS Appl Bio Mater
1 Afr J Reprod Health
1 Am J Case Rep
1 Am J Clin Pathol
1 Ann Acad Med Singap
1 APMIS
1 Appl Biochem Biotechnol
1 Arch Gynecol Obstet
1 Bioinform Adv
1 Biomed Pap Med Fac Univ Palacky Olomouc Czech Repu
1 BMC Neurol
3 BMC Public Health
3 BMC Womens Health
1 BMJ Open
1 Br J Cancer
1 Bull Exp Biol Med
1 Cancer Causes Control
1 Cancer Control
1 Cancer Discov
1 Cancer Gene Ther
1 Cancer Sci
3 Cancers (Basel)
1 Cell Death Dis
1 Cell Death Discov
1 Clin Med Res
1 Clin Transl Med
1 Commun Biol
1 Curr Pharm Biotechnol
1 Eur J Contracept Reprod Health Care
1 Gynecol Oncol
1 Gynecol Oncol Rep
1 IEEE J Transl Eng Health Med
1 Implement Sci Commun
1 Int Immunopharmacol
2 Int J Cancer
1 Int J Clin Oncol
8 Int J Gynecol Cancer
2 Int J Mol Sci
1 Int J Womens Health
1 J Biochem Mol Toxicol
1 J Epidemiol Glob Health
1 J Gynecol Obstet Hum Reprod
2 J Gynecol Oncol
1 J Natl Cancer Inst
1 J Transl Med
1 JAMA
1 JAMA Netw Open
2 Lancet Public Health
1 Med Phys
2 Medicine (Baltimore)
1 Obstet Gynecol Int
1 Oncol Res
1 PLoS One
1 Redox Biol
1 Res Sq
1 Rev Med Virol
3 Sci Rep
1 Sex Transm Dis
1 Transl Cancer Res
1 Virol Sin
1 Zhonghua Bing Li Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    ACS Appl Bio Mater

  1. MURUGAIYAN K, Srivastava R, Balaraman J, Eswar K, et al
    Gold-Coated Glybosomes Mimicking Physiological Micelles for ROS-Mediated Photothermal Ablation against Cervical Cancer.
    ACS Appl Bio Mater. 2026 Jan 8. doi: 10.1021/acsabm.5c02289.
    PubMed         Abstract available


    Afr J Reprod Health

  2. PENG D, Zhang A, Zhang Y
    Bridging digital divides: A quantitative assessment of equity, access, and determinants of AI adoption for women's reproductive cancer care in China.
    Afr J Reprod Health. 2025;29.
    PubMed         Abstract available


    Am J Case Rep

  3. QIAN XF, Wang XW, Yi HQ, Li LF, et al
    Peritoneal Post-Radiation Angiosarcoma in a Patient With a History of Radiation for Cervical Cancer.
    Am J Case Rep. 2026;27:e949701.
    PubMed         Abstract available


    Am J Clin Pathol

  4. SEEMAAB A, Colaizzi A, Matsko J, Ye Y, et al
    Assessment of microorganism detection in ThinPrep Papanicolaou tests utilizing the Hologic Genius Digital Diagnostics System.
    Am J Clin Pathol. 2025;164:946-952.
    PubMed         Abstract available


    Ann Acad Med Singap

  5. NANDAKUMAR V, Krishnan S, Chang CP, Yee S, et al
    High-risk human papillomavirus genotype prevalence in Singapore cervical samples: Implications for clinical management.
    Ann Acad Med Singap. 2025;54:758-765.
    PubMed         Abstract available


    APMIS

  6. LIU R, Liang L, Wang J, Wang M, et al
    Optimization of Liquid-Based Cytology Block Preparation Using Modified Adhesive Centrifugal Sedimentation for Improved Diagnostic Accuracy in Cervical Lesions.
    APMIS. 2026;134:e70131.
    PubMed         Abstract available


    Appl Biochem Biotechnol

  7. LIU J, Lei L, Liu Y, Wu J, et al
    Tanshinone I Promotes Ferroptosis of Cervical Cancer Cells by Activating the ATF3-Mediated Transcriptional Inhibition of FSP1.
    Appl Biochem Biotechnol. 2026 Jan 9. doi: 10.1007/s12010-025-05535.
    PubMed        


    Arch Gynecol Obstet

  8. WANG K, Si L, Zhao M, Guo R, et al
    Preoperative assessment of tumor size by MRI and ultrasound in cervical cancer: a large-scale retrospective comparative study.
    Arch Gynecol Obstet. 2026;313:23.
    PubMed         Abstract available


    Bioinform Adv

  9. PAI N, Rao JS
    Data-based clustering in prediction of cervical cancer DNA methylation using pan-cancer genetic and clinical data.
    Bioinform Adv. 2025;6:vbaf316.
    PubMed         Abstract available


    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repu

  10. ROMANOVA M, Klat J
    Prognostic significance of L1CAM in cervical cancer: A narrative review.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2026.
    PubMed         Abstract available


    BMC Neurol

  11. ZONG Y, Zhang D, Li Y, Wang P, et al
    Rare early-onset radiation-induced lumbosacral plexopathy in cervical cancer: a case report.
    BMC Neurol. 2026 Jan 8. doi: 10.1186/s12883-025-04601.
    PubMed        


    BMC Public Health

  12. ALIZADEH L, Keshavarz Z, Shalbaf A, Iranpour S, et al
    Iranian women's perceptions of human papillomavirus and barriers to vaccination: a qualitative study based on the health belief model.
    BMC Public Health. 2025;26:5.
    PubMed         Abstract available

  13. LAM MCY, Mbogo BW, Plaunt E, Mukankaka S, et al
    Transport stipend to facilitate cancer early detection: experiences of beneficiaries and perspectives of program personnel in Rwanda.
    BMC Public Health. 2025;26:13.
    PubMed         Abstract available

  14. ABUDUREXITI G, Muhetaer K, Yang J, Zhuo Q, et al
    HPV vaccine knowledge gaps and vaccination intent: a cross-sectional study of vocational students in Southern Xinjiang of China in 2023.
    BMC Public Health. 2025;26:102.
    PubMed         Abstract available


    BMC Womens Health

  15. LOVKIEL A, Petersen LK
    Increasing cervical cancer screening participation: a cluster-randomized pilot study at a department of gynaecology.
    BMC Womens Health. 2026 Jan 9. doi: 10.1186/s12905-025-04250.
    PubMed        

  16. CHATTERJEE R
    Sexual assault and cancer pathways: a scoping review of biomedical and screening outcomes.
    BMC Womens Health. 2025;26:16.
    PubMed         Abstract available

  17. HERNANDEZ A, Burrowes S, Gelaw B, Abede T, et al
    Is there a difference in sample adequacy when vaginal HPV DNA samples are self-collected at home, a health post, or a primary care health center in rural Ethiopia? Implications for community cervical cancer screening.
    BMC Womens Health. 2026 Jan 7. doi: 10.1186/s12905-025-04226.
    PubMed         Abstract available


    BMJ Open

  18. FANG H, Mu J, Chow EP, Ong JJ, et al
    Chinese caregivers' preferences and predicted uptake of HPV vaccination: a study protocol for two discrete choice experiments.
    BMJ Open. 2026;16:e089565.
    PubMed         Abstract available


    Br J Cancer

  19. WANG M, Fan J, Mu B, Zeng Y, et al
    HDAC5 stabilization by tubeimoside I suppresses cervical cancer metastasis via inhibiting H3K27ac/KPNA2 axis.
    Br J Cancer. 2026 Jan 8. doi: 10.1038/s41416-025-03328.
    PubMed         Abstract available


    Bull Exp Biol Med

  20. FAN QQ, Qin HF, Liu YQ
    Artemisinin Inhibits Drug Resistance and Epithelial-Mesenchymal Transition in Cervical Cancer Cells via the Wnt/beta-Catenin Signaling Pathway.
    Bull Exp Biol Med. 2026 Jan 8. doi: 10.1007/s10517-026-06540.
    PubMed         Abstract available


    Cancer Causes Control

  21. DA SILVA LOUZA LG, de Sousa Gomes ML, Oria MOB, Rafael EV, et al
    Applicability of the levels of the socio-ecological model in the context of cervical cancer prevention: a scoping review.
    Cancer Causes Control. 2026;37:16.
    PubMed         Abstract available


    Cancer Control

  22. SURMAVA S, Kvaratskhelia E, Davitashvili B, Vardiashvili N, et al
    Exploratory Analysis of Candidate Gene SNPs in Relation to Cervical Cancer Susceptibility in Georgian Women.
    Cancer Control. 2026;33:10732748251413338.
    PubMed         Abstract available


    Cancer Discov

  23. LAN C, Zhang P, Zhao J, Li Q, et al
    Spatiotemporal Immune Determinants of Response to Immune Rechallenge in Advanced Cervical Cancer.
    Cancer Discov. 2026 Jan 9. doi: 10.1158/2159-8290.CD-25-0467.
    PubMed         Abstract available


    Cancer Gene Ther

  24. GONG Y, Wu J, Hu Y
    m(6)A epitranscriptomic regulation of KRAS by METTL3 promotes EMT and stromal remodeling through TGF-beta/SMAD signaling in cervical cancer.
    Cancer Gene Ther. 2026 Jan 3. doi: 10.1038/s41417-025-00993.
    PubMed         Abstract available


    Cancer Sci

  25. KOBAYASHI M, Nakagawa S, Ishii Y, Kamei Y, et al
    VRK1 Is a Novel Therapeutic Target for Small Cell Neuroendocrine Carcinoma of the Cervix.
    Cancer Sci. 2026;117:78-89.
    PubMed         Abstract available


    Cancers (Basel)

  26. SEMINARIO N, Bebia V, Luzarraga Aznar A, Jose MS, et al
    Postvoid Residual Volume After Radical Hysterectomy for Early-Stage Cervical Cancer: Predictive Factors and a Decision-Making Algorithm.
    Cancers (Basel). 2025;18:24.
    PubMed         Abstract available

  27. GORECKI G, Hale M, Taylor S, Garcia G, et al
    Prognostic Value of Lymphoid Infiltration and Aggregation in Cervical Cancer.
    Cancers (Basel). 2025;18:129.
    PubMed         Abstract available

  28. WANG M, Cao Y, Zhang W, Liang Y, et al
    Prediction Model of Lymph Node Metastasis in Cervical Cancer Based on MRI Habitat Radiomics.
    Cancers (Basel). 2025;18:152.
    PubMed         Abstract available


    Cell Death Dis

  29. WANG L, Li X, Ren C, Liu L, et al
    Site-specific HPV18 integration facilitates cervical carcinogenesis through metabolic reprogramming-induced dysfunction of the SpHK1/S1P/S1PR1 pathway.
    Cell Death Dis. 2026;17:24.
    PubMed         Abstract available


    Cell Death Discov

  30. ZHANG R, Chai S, Zhang F, Lai J, et al
    Hypoxia promotes progression of cervical cancer by modulating the ATXN3-enhanced P53 stability or STAT5 phosphorylation.
    Cell Death Discov. 2026;12:4.
    PubMed         Abstract available


    Clin Med Res

  31. OSHIKANLU BC, Sowunmi AC, Habeebu MY, Dada AO, et al
    Serum Squamous Cell Carcinoma Markers: A Case-Control Study for Cervical Cancer.
    Clin Med Res. 2025;23:129-136.
    PubMed         Abstract available


    Clin Transl Med

  32. XIN W, Zhang J, Wu D, Cai Y, et al
    VAMP7-mediated autophagy regulates cervical cancer progression associated with persistent HPV16 infection.
    Clin Transl Med. 2026;16:e70590.
    PubMed         Abstract available


    Commun Biol

  33. WU Y, Wei B, Wei Z, Wang H, et al
    Single-cell and spatial transcriptomic profiling reveals distinct tumor microenvironment dynamics in cervical adenocarcinoma and squamous cell carcinoma.
    Commun Biol. 2025;9:46.
    PubMed         Abstract available


    Curr Pharm Biotechnol

  34. BEREZA K, Banas T, Grabarek BO, Czerw A, et al
    Levels of Systemic Inflammatory Markers in Women with Cervical Cancer Undergoing Definitive Chemoradiotherapy Depend Primarily on Pre-treatment and Post-teletherapy Tumor Volume, Rather than on the Prescribed Radiation Dose.
    Curr Pharm Biotechnol. 2026 Jan 6. doi: 10.2174/0113892010413911251122074226.
    PubMed         Abstract available


    Eur J Contracept Reprod Health Care

  35. KHASTGIR G, Saha PK, Bagga R
    From hesitancy to hope: charting India's path to widespread HPV immunisation.
    Eur J Contracept Reprod Health Care. 2026;31:53-58.
    PubMed         Abstract available


    Gynecol Oncol

  36. TANG W, Wang L, Li X, Yan X, et al
    Radiation-induced acquired expression of PD-L1 and reprogramming of the tumor microenvironment in cervical cancer.
    Gynecol Oncol. 2026;205:17-26.
    PubMed         Abstract available


    Gynecol Oncol Rep

  37. OLTHOF EP, Oostveen NA, van der Aa MA, Bekkers RLM, et al
    Prognostic and therapeutic implications of clinical-radiologic discrepancy in parametrial invasion prior to primary radical hysterectomy in cervical cancer.
    Gynecol Oncol Rep. 2025;63:102002.
    PubMed         Abstract available


    IEEE J Transl Eng Health Med

  38. JURJUT O, Weiss M, Daniel Y, Matovina S, et al
    Detection of Cervical Intraepithelial Neoplasia Using Hyperspectral Tissue Signatures.
    IEEE J Transl Eng Health Med. 2025;13:532-539.
    PubMed         Abstract available


    Implement Sci Commun

  39. OYARO B, Wanje G, Richardson BA, Temmerman M, et al
    A mixed-methods assessment of individual client-level and clinic-level factors associated with uptake of cervical cancer screening (CCS) services in family planning (FP) clinics receiving an intervention to support these services in Mombasa County, Ke
    Implement Sci Commun. 2026 Jan 9. doi: 10.1186/s43058-025-00852.
    PubMed         Abstract available


    Int Immunopharmacol

  40. LIU X, Guo L, Zhang H, Xue L, et al
    Multi-omics profiling reveals that targeting NEK3 synergizes with cuproptosis to promote M1 macrophage polarization in cervical cancer.
    Int Immunopharmacol. 2026;171:116128.
    PubMed         Abstract available


    Int J Cancer

  41. PALMER TJ, Kavanagh K, Cuschieri K, Cameron RL, et al
    Sustained impact of bivalent HPV immunisation on CIN incidence over two rounds of cervical screening.
    Int J Cancer. 2025 Nov 3. doi: 10.1002/ijc.70183.
    PubMed         Abstract available

  42. KALJOUW S, Jansen EEL, Olthof EMG, Hontelez JAC, et al
    Under which realistic circumstances is hrHPV self-sampling increasing cervical screening effectiveness in a partly vaccinated population? A modelling study.
    Int J Cancer. 2026;158:1361-1369.
    PubMed         Abstract available


    Int J Clin Oncol

  43. KITAMI K, Kuji S, Kamiya N, Machida H, et al
    Real-world safety and efficacy of immune checkpoint inhibitors in Japanese patients with persistent, recurrent, or metastatic cervical cancer: a multicenter prospective and retrospective study.
    Int J Clin Oncol. 2026 Jan 8. doi: 10.1007/s10147-025-02951.
    PubMed         Abstract available


    Int J Gynecol Cancer

  44. CIBULA D, Mburu A, Planchamp F, Zapardiel I, et al
    European Society of Gynaecological Oncology resource-stratified guidelines for the management of patients with cervical cancer.
    Int J Gynecol Cancer. 2026;36:102747.
    PubMed         Abstract available

  45. LEE SS, Banson K, Koduru H, Berger AA, et al
    Factors associated with treatment delay for cervical cancer patients treated with definitive chemoradiation and brachytherapy.
    Int J Gynecol Cancer. 2026;36:102774.
    PubMed         Abstract available

  46. TORIGOE R, Dennen C, Mayadev J, Makale MT, et al
    Current challenges in the assessment and management of radiotherapy-induced vaginal stenosis.
    Int J Gynecol Cancer. 2026;36:102801.
    PubMed         Abstract available

  47. WU Q, Qiu X, Peng R
    Correspondence on "Role of the novel optoelectronic imaging tracing system in cervical cancer screening: preliminary outcomes of a multi-center study" by Xiao Shang et al.
    Int J Gynecol Cancer. 2025 Dec 16:102873. doi: 10.1016/j.ijgc.2025.102873.
    PubMed        

  48. WANG K, Zhai Q, Xie Y, Tian Y, et al
    Sentinel node mapping with carbon nanoparticles versus lymphadenectomy in early cervical cancer.
    Int J Gynecol Cancer. 2025;36:102881.
    PubMed         Abstract available

  49. CIANCIA M, Mascilini F, Moro F, Testa AC, et al
    Response to the Correspondence by Xu et al. on "Diagnostic performance of ultrasound-guided biopsy for detecting recurrent or persistent cervical cancer after chemoradiotherapy: a prospective, single-center study" by Mascilini et al.
    Int J Gynecol Cancer. 2025 Dec 18:102882. doi: 10.1016/j.ijgc.2025.102882.
    PubMed        

  50. MARUCCI DA SILVA GF, Pilger TL, Candido Dos Reis FJ
    Incidence of urologic co-morbidities after abdominal radical hysterectomy: a systematic review of clinical trials.
    Int J Gynecol Cancer. 2026;36:102722.
    PubMed         Abstract available

  51. WILLIAMS G, Bindra A, Fink D, Weintraub MR, et al
    Survival in human papillomavirus and non-human papillomavirus-associated invasive endocervical adenocarcinoma: outcomes in a large, integrated healthcare system.
    Int J Gynecol Cancer. 2026;36:102683.
    PubMed         Abstract available


    Int J Mol Sci

  52. KESZTHELYI M, Sziva RE, Havran Z, Szabo V, et al
    Systemic Inflammatory Indices-Systemic Immune-Inflammation Index (SII) and the Systemic Inflammation Response Index (SIRI)-As Potential Rule-Out Biomarkers for Invasive Cervical Carcinoma.
    Int J Mol Sci. 2025;27:435.
    PubMed         Abstract available

  53. ALVARADO-CAMACHO DA, Castillo-Velazquez R, Granados-Lopez AJ, Hernandez-Lopez H, et al
    Differentially Expressed Genes Associated with the Development of Cervical Cancer.
    Int J Mol Sci. 2025;27:258.
    PubMed         Abstract available


    Int J Womens Health

  54. YUAN H, Wang X, Liu K, Zhang J, et al
    Immune Checkpoint-Related Gene Polymorphisms and High Serum Concentration of PD-L1 and CTLA4 Contribute to the Resistance to Platinum-Based Chemotherapy in Cervical Cancer.
    Int J Womens Health. 2025;17:5719-5731.
    PubMed         Abstract available


    J Biochem Mol Toxicol

  55. LI H, Ahmad M, Zhou D
    Relaxin-2 Inhibits Cervical Cancer Growth by Downregulating Kruppel-Like Factor 5 (KLF5) Through the Inhibition of Hippo-YAP and JAK2/STAT3 Signaling Pathways.
    J Biochem Mol Toxicol. 2026;40:e70687.
    PubMed         Abstract available


    J Epidemiol Glob Health

  56. ALHMEID EK, Aldohni AAA, Alghanim AI, Salha RM, et al
    Sociodemographic Determinants of Cervical Cancer Screening among Ever-Married Women in Jordan: Insights from the 2023 Jordan Population and Family Health Survey.
    J Epidemiol Glob Health. 2026;16:5.
    PubMed         Abstract available


    J Gynecol Obstet Hum Reprod

  57. VAN LONKHUIJZEN L, Mom CH, van der Aa M
    Cervical cancer in women eligible for HPV-vaccination in the Netherlands.
    J Gynecol Obstet Hum Reprod. 2026 Jan 6:103107. doi: 10.1016/j.jogoh.2026.103107
    PubMed        


    J Gynecol Oncol

  58. WANG S, Zhu Q, Lu Y, Yang X, et al
    Update of incidence and survival in patients with cervical cancer in the United States from 2000 to 2021.
    J Gynecol Oncol. 2026 Dec 18. doi: 10.3802/jgo.2026.
    PubMed         Abstract available

  59. FAN C, Fu C
    Cross-country inequalities and frontier analysis in global burden of cervical cancer: cross-sectional studies.
    J Gynecol Oncol. 2026 Dec 18. doi: 10.3802/jgo.2026.
    PubMed         Abstract available


    J Natl Cancer Inst

  60. JIANG C, Rosenberg PS, Jemal A, Sung H, et al
    Cervical cancer incidence rates by birth cohort against the backdrop of human papillomavirus vaccination in the United States.
    J Natl Cancer Inst. 2026 Jan 7:djaf374. doi: 10.1093.
    PubMed         Abstract available


    J Transl Med

  61. LU R, Zhang J, Ma X, Feng Y, et al
    Dual-dimensional profiling of host genomic variations and HPV integration in PD-L1-stratified cervical cancer via Oxford Nanopore Technology.
    J Transl Med. 2026 Jan 7. doi: 10.1186/s12967-025-07674.
    PubMed        


    JAMA

  62. CHRISTINE B, Bush M, Thurakal A, Sheehy AM, et al
    New Cervical Cancer Screening Guidelines From the US Department of Health and Human Services: Strengthening Women's Preventive Health.
    JAMA. 2026 Jan 5. doi: 10.1001/jama.2025.26456.
    PubMed        


    JAMA Netw Open

  63. GANGULY AP, Pretsch PK, Brewer NT, Spees LP, et al
    Streamlined Self-Collection Screening for Sexually Transmitted Infections and Human Papillomavirus: A Single-Group Secondary Analysis of a Randomized Clinical Trial.
    JAMA Netw Open. 2026;9:e2551345.
    PubMed         Abstract available


    Lancet Public Health

  64. MEGLIC E, Ploner A, Clements M, Elfstrom M, et al
    Herd effect of human papillomavirus vaccination on incidence of high-grade cervical lesions: a population-based cohort study in Sweden.
    Lancet Public Health. 2026;11:e35-e43.
    PubMed         Abstract available

  65. PATEL MS, Patel KS, Willmann J, Feliciano EJG, et al
    Cervical cancer screening beyond traditional barriers.
    Lancet Public Health. 2026;11:e6.
    PubMed        


    Med Phys

  66. PEPPA V, Robitaille M, Akbari F, Enger SA, et al
    Clinical test cases for commissioning, QA, and benchmarking of model-based dose calculation algorithms in (1)(9)(2)Ir HDR gynecologic tandem and ring brachytherapy.
    Med Phys. 2026;53:e70260.
    PubMed         Abstract available


    Medicine (Baltimore)

  67. YUAN K, Bai Y, Chen S, Shi Y, et al
    The effects of earthworm fibrinolytic enzyme on cervical cancer Caski cells based on CiteSpace and VOSviewer visual analysis.
    Medicine (Baltimore). 2026;105:e46783.
    PubMed         Abstract available

  68. ZHAI J, Pang T, An Y, Wang J, et al
    Clinical significance of CXCL17 in cervical cancer.
    Medicine (Baltimore). 2026;105:e46178.
    PubMed         Abstract available


    Obstet Gynecol Int

  69. KABIR SF, Ashik-Ur-Rahman M, Rahman A, Hossen MA, et al
    Factors Associated With Low Utilization of Cervical Cancer Screening Services in Gazipur, Bangladesh.
    Obstet Gynecol Int. 2025;2025:4476955.
    PubMed         Abstract available


    Oncol Res

  70. SINNO AK, Mustapha A, Nair N, Zaami S, et al
    Circulating Tumor DNA in Cervical Cancer: Clinical Utility and Medico-Legal Perspectives.
    Oncol Res. 2025;34:4.
    PubMed         Abstract available


    PLoS One

  71. HU J, Wang Y, Liu Y, Cai Z, et al
    Global burden and projections of cervical cancer attributable to unsafe sex and smoking, 1990-2034.
    PLoS One. 2026;21:e0339923.
    PubMed         Abstract available


    Redox Biol

  72. SOLTAU CP, Sinha D, Patil LP, Moseley PM, et al
    Redox-active nitroxides enhance cisplatin efficacy against cervical cancer.
    Redox Biol. 2025;89:103989.
    PubMed         Abstract available


    Res Sq

  73. ZHANG L, Mwita CJ, Soliman GA, Mushi DF, et al
    Nutritional Status of Patients Diagnosed with Cervical Cancer in Tanzania.
    Res Sq [Preprint]. 2025 Dec 18:rs.3.rs-7780798. doi: 10.21203/rs.3.rs-7780798.
    PubMed         Abstract available


    Rev Med Virol

  74. SABEENA S, Beynon C
    The Impact of the COVID-19 Pandemic on HPV Vaccination Coverage Among Adolescents From High-Income Countries and Challenges: A Scoping Review.
    Rev Med Virol. 2026;36:e70102.
    PubMed         Abstract available


    Sci Rep

  75. LI F, Wei Z, Tao M, Zhao K, et al
    Notch1(+) cervical cancer cells may promote perineural invasion by secreting neurotrophin-4.
    Sci Rep. 2026 Jan 8. doi: 10.1038/s41598-025-34812.
    PubMed        

  76. GETIE B, Wondimu E, Almaw A, Legese B, et al
    Prevalence and risk factors of high-risk cervical HPV infections among women attending Debre Tabor hospital family planning and gynecology clinic, Northcentral Ethiopia.
    Sci Rep. 2025;16:779.
    PubMed         Abstract available

  77. CALFA S, de Freitas AJA, Causin RL, Hirai W, et al
    Exploring shared microRNA profiles in liquid-based cytology and plasma as biomarkers of high-grade intraepithelial lesions.
    Sci Rep. 2025;16:828.
    PubMed         Abstract available


    Sex Transm Dis

  78. BROSHKEVITCH CJ, Pretsch PK, Spees LP, Wheeler SB, et al
    Underscreened Women's Reactions to At-Home Self-Collected Human Papillomavirus Test Result Delivery.
    Sex Transm Dis. 2026;53:109-115.
    PubMed         Abstract available


    Transl Cancer Res

  79. ZHANG LL, Ji YF, Li J, Wang WH, et al
    Construction of a prognostic model based on efferocytosis for predicting survival and immunotherapy efficacy in cervical cancer.
    Transl Cancer Res. 2025;14:8908-8929.
    PubMed         Abstract available


    Virol Sin

  80. LIU Y, Han Z, Kaminski P, Tao C, et al
    Topoisomerase IIalpha orchestrates secretion of IL-6 and IL-8 with human papillomavirus replication.
    Virol Sin. 2025;40:946-961.
    PubMed         Abstract available


    Zhonghua Bing Li Xue Za Zhi

  81. MA LL, Yang SJ
    [Mucosal melanoma with atypical EWSR1 break-apart signal arising in the cervix and vagina: report of a case].
    Zhonghua Bing Li Xue Za Zhi. 2026;55:93-95.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.